Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.24.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Schedule Of Outstanding Pre-funded Warrants Basic And Diluted Net Loss Per Share

The following outstanding pre-funded warrants as of June 30, 2024 and 2023 were included in the basic and diluted net loss per share calculation (refer to Note 10):

 

 

 

As of June 30,

 

 

 

2024

 

 

2023

 

2020 Pre-Funded Warrants, issued in the 2020 Private Placement

 

 

100,000

 

 

 

100,000

 

2022 Pre-Funded Warrants, issued in the 2022 Private Placement

 

 

7,179,819

 

 

 

7,279,819

 

2023 Pre-Funded Warrants, issued in December 2023 registered direct offering

 

 

5,242,588

 

 

 

 

Total

 

 

12,522,407

 

 

 

7,379,819

 

 

 

 

 

 

 

 

Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share

The following common stock equivalents were excluded from the calculation of diluted net loss per share applicable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

As of June 30,

 

 

 

2024

 

 

2023

 

Stock options

 

 

1,533,059

 

 

 

1,747,357

 

Unvested restricted stock units

 

 

3,072,224

 

 

 

2,321,582

 

Warrants*

 

 

14,142,298

 

 

 

14,142,298

 

Total

 

 

18,747,581

 

 

 

18,211,237

 

* As of June 30, 2024 and 2023, this is comprised of 2,754 warrants to purchase common stock issued in connection with the execution and first draw of the Company’s loan agreement in February 2020 (refer to Note 7), 1,738 warrants to purchase common stock issued in connection with the second draw on this loan agreement in December 2020 (refer to

Note 7), 282,809 warrants to purchase common stock issued in connection with the private placement in December 2020 (refer to Note 10), 13,813,912 warrants to purchase common stock issued in connection with the private placement in September 2022 (refer to Note 10), and 41,085 warrants to purchase common stock that were issued upon the assumption and conversion of warrants in connection with the acquisition of Tyme Technologies, Inc.